ARTICLE | Clinical News
TroVax: Phase II started
March 11, 2013 7:00 AM UTC
Oxford BioMedica said the Velindre Cancer Centre began the open-label, U.K. Phase II SKOPOS trial to evaluate TroVax every 3 weeks for 9 cycles plus pemetrexed and cisplatin in 26 patients. The trial ...